Pharmafile Logo
Pharmafocus logo
Advanced Search

opioid

Showing 15 posts of 33 posts found.

800px-temazepam_10mg_tablets-1_1

Canada to roll out automated drug dispensers to help fight opioid crisis

August 27, 2020
Research and Development opioid, opioid crisis, opioids

Canada is set to roll out automated drug dispensers that can provide clean, doctor-prescribed medicine to opioid addicts by scanning …

News
bojo

UK Government officially announces National Institute for Health Protection to replace Public Health England

August 19, 2020
Research and Development opioid, opioid crisis, opioid epidemic

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection. …

News
purdue

Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer

July 7, 2020
Manufacturing and Production Purdue, opioid, opioid crisis

Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He …

News
40542895134_9f6048fa40_b

FDA panel votes against Nektar opioid painkiller

January 15, 2020
Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …

News
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020
Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …

News
920x920

Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows

December 17, 2019
Manufacturing and Production Oxy, OxyContin, Purdue Pharma, Sackler family, opioid, opioid crisis, sackler

An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 …

News
trvn1

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018
Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

News

US Senate pass bipartisan bill to tackle opioid crisis

September 18, 2018
Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics

The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …

News

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …

News
24327909026_6435de0904_z

Ketamine’s antidepressant effects may be linked to brain’s opioid system

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid

Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …

News

Letters to doctors reduce opioid prescriptions, study shows

August 10, 2018
Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study

A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …

News

Insys Therapeutics reaches $150m agreement to settle opioid marketing case

August 9, 2018
Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma

The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …

News
US regulators FDA building

FDA rejects Insys Therapeutics sublingual opioid spray

July 31, 2018
Manufacturing and Production Crisis, FDA, insys, opioid, rejection, spray

The FDA has rejected Insys Therapeutics buprenorphine sublingual spray due to concerns about the safety of the Arizona-based company’s opioid …

News
Toronto, Ontario skyline

Illegally manufactured fentanyl drives deaths in Ontario

July 5, 2018
Medical Communications Crisis, Ontario, canda, epidemic, fentanyl, opioid

Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …

News
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018
Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024